Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the In Vivo and In Vitro ADME and PK industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Tecan Group
ICON
Joinn Laboratories
WuXi AppTec
Evotec
Syneos Health
Eurofins Scientific
Aragen Life Sciences
RTI International
Labcorp
Charles River
Bioduro-Sundia
Pharmaron
ChemPartner
Sai Life Sciences
Shanghai Medicilon
Curia
By Type:
Biologics
Small Molecules
By Application:
Others
Biopharmaceutical Companies
Government and Academic Institutes
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China In Vivo and In Vitro ADME and PK Market Overview 2018-2029
-
1.1 China In Vivo and In Vitro ADME and PK Industry Development Overview
-
1.2 China In Vivo and In Vitro ADME and PK Industry Development History
-
1.3 China In Vivo and In Vitro ADME and PK Industry Market Size (2018-2029)
-
1.4 China In Vivo and In Vitro ADME and PK Market Analysis by Type from Production Side
-
1.4.1 China In Vivo and In Vitro ADME and PK Production Volume, Production Value and Growth Rate of Biologics (2018-2029)
-
1.4.2 China In Vivo and In Vitro ADME and PK Production Volume, Production Value and Growth Rate of Small Molecules (2018-2029)
-
1.5 China In Vivo and In Vitro ADME and PK Market Analysis by Application from Consumption End
-
1.5.1 China In Vivo and In Vitro ADME and PK Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China In Vivo and In Vitro ADME and PK Sales Volume, Sales Value and Growth Rate of Biopharmaceutical Companies (2018-2029)
-
1.5.3 China In Vivo and In Vitro ADME and PK Sales Volume, Sales Value and Growth Rate of Government and Academic Institutes (2018-2029)
-
1.6 China In Vivo and In Vitro ADME and PK Market Analysis by Region
-
1.6.1 North China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
1.6.3 South China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
1.6.4 East China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
Chapter 2 China In Vivo and In Vitro ADME and PK Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on In Vivo and In Vitro ADME and PK Market Status and Competition at home and abroad in 2023
-
2.2.2 China In Vivo and In Vitro ADME and PK Market Status and Competition Analysis in 2023
-
2.2.3 China In Vivo and In Vitro ADME and PK Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China In Vivo and In Vitro ADME and PK Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on In Vivo and In Vitro ADME and PK Industry Development
Chapter 3 In Vivo and In Vitro ADME and PKIndustry Chain Analysis
-
3.1 In Vivo and In Vitro ADME and PK Industry Chain
-
3.2 In Vivo and In Vitro ADME and PK Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the In Vivo and In Vitro ADME and PK Market
-
3.3 In Vivo and In Vitro ADME and PK Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the In Vivo and In Vitro ADME and PK Market
Chapter 4 China In Vivo and In Vitro ADME and PK Market, by Type
-
4.1 China In Vivo and In Vitro ADME and PK Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China In Vivo and In Vitro ADME and PK Total Production Volume and Growth Rate from Production Side
-
4.5 China In Vivo and In Vitro ADME and PK Production Volume and Growth Rate, by Type
-
4.5.1 China In Vivo and In Vitro ADME and PK Production Volume and Growth Rate of Biologics
-
4.5.2 China In Vivo and In Vitro ADME and PK Production Volume and Growth Rate of Small Molecules
Chapter 5 China In Vivo and In Vitro ADME and PK Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China In Vivo and In Vitro ADME and PK Total Market Size and Growth Rate from Consumption End
-
5.5 China In Vivo and In Vitro ADME and PK Market Size and Growth Rate, by Application
-
5.5.1 China In Vivo and In Vitro ADME and PK Market Size and Growth Rate of Others
-
5.5.2 China In Vivo and In Vitro ADME and PK Market Size and Growth Rate of Biopharmaceutical Companies
-
5.5.3 China In Vivo and In Vitro ADME and PK Market Size and Growth Rate of Government and Academic Institutes
Chapter 6 China In Vivo and In Vitro ADME and PK Market, by Region
-
6.1 China In Vivo and In Vitro ADME and PK Production Volume and Production Value, by Region
-
6.2 China In Vivo and In Vitro ADME and PK Sales Volume and Sales Value, by Region
Chapter 7 North China In Vivo and In Vitro ADME and PK Market Analysis
-
7.1 North China In Vivo and In Vitro ADME and PK Market, by Type
-
7.2 North China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 8 Central China In Vivo and In Vitro ADME and PK Market Analysis
-
8.1 Central China In Vivo and In Vitro ADME and PK Market, by Type
-
8.2 Central China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 9 South China In Vivo and In Vitro ADME and PK Market Analysis
-
9.1 South China In Vivo and In Vitro ADME and PK Market, by Type
-
9.2 South China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 10 East China In Vivo and In Vitro ADME and PK Market Analysis
-
10.1 East China In Vivo and In Vitro ADME and PK Market, by Type
-
10.2 East China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 11 Northeast China In Vivo and In Vitro ADME and PK Market Analysis
-
11.1 Northeast China In Vivo and In Vitro ADME and PK Market, by Type
-
11.2 Northeast China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 12 Southwest China In Vivo and In Vitro ADME and PK Market Analysis
-
12.1 Southwest China In Vivo and In Vitro ADME and PK Market, by Type
-
12.2 Southwest China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 13 Northwest China In Vivo and In Vitro ADME and PK Market Analysis
-
13.1 Northwest China In Vivo and In Vitro ADME and PK Market, by Type
-
13.2 Northwest China In Vivo and In Vitro ADME and PK Market, by Application
Chapter 14 Company Profiles
-
14.1 Tecan Group
-
14.1.1 Tecan Group Company Profile
-
14.1.2 Tecan Group In Vivo and In Vitro ADME and PK Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 ICON
-
14.2.1 ICON Company Profile
-
14.2.2 ICON In Vivo and In Vitro ADME and PK Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Joinn Laboratories
-
14.3.1 Joinn Laboratories Company Profile
-
14.3.2 Joinn Laboratories In Vivo and In Vitro ADME and PK Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 WuXi AppTec
-
14.4.1 WuXi AppTec Company Profile
-
14.4.2 WuXi AppTec In Vivo and In Vitro ADME and PK Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Evotec
-
14.5.1 Evotec Company Profile
-
14.5.2 Evotec In Vivo and In Vitro ADME and PK Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Syneos Health
-
14.6.1 Syneos Health Company Profile
-
14.6.2 Syneos Health In Vivo and In Vitro ADME and PK Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Eurofins Scientific
-
14.7.1 Eurofins Scientific Company Profile
-
14.7.2 Eurofins Scientific In Vivo and In Vitro ADME and PK Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Aragen Life Sciences
-
14.8.1 Aragen Life Sciences Company Profile
-
14.8.2 Aragen Life Sciences In Vivo and In Vitro ADME and PK Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 RTI International
-
14.9.1 RTI International Company Profile
-
14.9.2 RTI International In Vivo and In Vitro ADME and PK Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Labcorp
-
14.10.1 Labcorp Company Profile
-
14.10.2 Labcorp In Vivo and In Vitro ADME and PK Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Charles River
-
14.11.1 Charles River Company Profile
-
14.11.2 Charles River In Vivo and In Vitro ADME and PK Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Bioduro-Sundia
-
14.12.1 Bioduro-Sundia Company Profile
-
14.12.2 Bioduro-Sundia In Vivo and In Vitro ADME and PK Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Pharmaron
-
14.13.1 Pharmaron Company Profile
-
14.13.2 Pharmaron In Vivo and In Vitro ADME and PK Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 ChemPartner
-
14.14.1 ChemPartner Company Profile
-
14.14.2 ChemPartner In Vivo and In Vitro ADME and PK Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Sai Life Sciences
-
14.15.1 Sai Life Sciences Company Profile
-
14.15.2 Sai Life Sciences In Vivo and In Vitro ADME and PK Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Shanghai Medicilon
-
14.16.1 Shanghai Medicilon Company Profile
-
14.16.2 Shanghai Medicilon In Vivo and In Vitro ADME and PK Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Curia
-
14.17.1 Curia Company Profile
-
14.17.2 Curia In Vivo and In Vitro ADME and PK Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 In Vivo and In Vitro ADME and PK Industry Research Conclusions
-
15.2 In Vivo and In Vitro ADME and PK Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China In Vivo and In Vitro ADME and PK Industry Market Size (2018-2029)
-
Figure China In Vivo and In Vitro ADME and PK Production Volume, Production Value and Growth Rate of Biologics (2018-2029)
-
Figure China In Vivo and In Vitro ADME and PK Production Volume, Production Value and Growth Rate of Small Molecules (2018-2029)
-
Figure China In Vivo and In Vitro ADME and PK Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China In Vivo and In Vitro ADME and PK Sales Volume, Sales Value and Growth Rate of Biopharmaceutical Companies (2018-2029)
-
Figure China In Vivo and In Vitro ADME and PK Sales Volume, Sales Value and Growth Rate of Government and Academic Institutes (2018-2029)
-
Figure North China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure Central China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure South China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure East China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure Northeast China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure Southwest China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure Northwest China In Vivo and In Vitro ADME and PK Market Size and Growth Rate from 2018-2029
-
Figure In Vivo and In Vitro ADME and PK Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China In Vivo and In Vitro ADME and PK Market Share by Type in 2018
-
Figure China In Vivo and In Vitro ADME and PK Market Share by Type in 2023
-
Figure China In Vivo and In Vitro ADME and PK Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Production Volume and Growth Rate of Biologics (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Production Volume and Growth Rate of Small Molecules (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Market Share by Application in 2018
-
Figure China In Vivo and In Vitro ADME and PK Market Share by Application in 2023
-
Figure China In Vivo and In Vitro ADME and PK Total Market Size and Growth Rate from Consumption End
-
Figure China In Vivo and In Vitro ADME and PK Market Size and Growth Rate of Others (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Market Size and Growth Rate of Biopharmaceutical Companies (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Market Size and Growth Rate of Government and Academic Institutes (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Production Volume by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Production Volume Share by Region (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Production Volume Share by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Production Value by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Production Value Share by Region (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Production Value Share by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Sales Volume by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Sales Volume Share by Region (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Sales Volume Share by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Sales Value by Region (2018-2023)
-
Table China In Vivo and In Vitro ADME and PK Sales Value Share by Region (2018-2023)
-
Figure China In Vivo and In Vitro ADME and PK Sales Value Share by Region (2018-2023)
-
Table North China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table North China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure North China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table North China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table North China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure North China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table Central China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table Central China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure Central China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table Central China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table Central China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure Central China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table South China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table South China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure South China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table South China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table South China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure South China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table East China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table East China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure East China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table East China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table East China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure East China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table Northeast China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table Northeast China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure Northeast China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table Northeast China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table Northeast China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure Northeast China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table Southwest China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table Southwest China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure Southwest China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table Southwest China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table Southwest China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure Southwest China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table Northwest China In Vivo and In Vitro ADME and PK Production Volume by Type (2018-2023)
-
Table Northwest China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Figure Northwest China In Vivo and In Vitro ADME and PK Production Volume Share by Type (2018-2023)
-
Table Northwest China In Vivo and In Vitro ADME and PK Sales Volume by Application (2018-2023)
-
Table Northwest China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Figure Northwest China In Vivo and In Vitro ADME and PK Sales Volume Share by Application (2018-2023)
-
Table Tecan Group Company Profile
-
Table Tecan Group In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table ICON Company Profile
-
Table ICON In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Joinn Laboratories Company Profile
-
Table Joinn Laboratories In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table WuXi AppTec Company Profile
-
Table WuXi AppTec In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Evotec Company Profile
-
Table Evotec In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Syneos Health Company Profile
-
Table Syneos Health In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Eurofins Scientific Company Profile
-
Table Eurofins Scientific In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Aragen Life Sciences Company Profile
-
Table Aragen Life Sciences In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table RTI International Company Profile
-
Table RTI International In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Labcorp Company Profile
-
Table Labcorp In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Charles River Company Profile
-
Table Charles River In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Bioduro-Sundia Company Profile
-
Table Bioduro-Sundia In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Pharmaron Company Profile
-
Table Pharmaron In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table ChemPartner Company Profile
-
Table ChemPartner In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Sai Life Sciences Company Profile
-
Table Sai Life Sciences In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Shanghai Medicilon Company Profile
-
Table Shanghai Medicilon In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
Table Curia Company Profile
-
Table Curia In Vivo and In Vitro ADME and PK Revenue, Price and Gross (2018-2023)
-
